133 related articles for article (PubMed ID: 28633916)
1. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
2. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel alternative splicing variants of Oct4 gene expressed in mouse pluripotent stem cells.
Liu X; Yu T; Sun Y; Wang H
J Cell Physiol; 2018 Jul; 233(7):5468-5477. PubMed ID: 29266259
[TBL] [Abstract][Full Text] [Related]
4. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
5. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
6. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.
Atlasi Y; Mowla SJ; Ziaee SA; Gokhale PJ; Andrews PW
Stem Cells; 2008 Dec; 26(12):3068-74. PubMed ID: 18787205
[TBL] [Abstract][Full Text] [Related]
7. Novel spliced variants of OCT4, OCT4C and OCT4C1, with distinct expression patterns and functions in pluripotent and tumor cell lines.
Malakootian M; Mirzadeh Azad F; Naeli P; Pakzad M; Fouani Y; Taheri Bajgan E; Baharvand H; Mowla SJ
Eur J Cell Biol; 2017 Jun; 96(4):347-355. PubMed ID: 28476334
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of OCT4 by the ETS transcription factor ESE-1 in NCCIT human embryonic carcinoma cells.
Park SW; Do HJ; Ha WT; Han MH; Yang HM; Lee SH; Song H; Kim NH; Kim JH
Biochem Biophys Res Commun; 2014 Jul; 450(2):984-90. PubMed ID: 24971534
[TBL] [Abstract][Full Text] [Related]
9. Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.
Wang X; Dai J
Stem Cells; 2010 May; 28(5):885-93. PubMed ID: 20333750
[TBL] [Abstract][Full Text] [Related]
10. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.
Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J
J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710
[TBL] [Abstract][Full Text] [Related]
11. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
12. Identification and differential expression patterns of porcine OCT4 variants.
Hwang JY; Oh JN; Lee DK; Choi KH; Park CH; Lee CK
Reproduction; 2015 Jan; 149(1):55-66. PubMed ID: 25342174
[TBL] [Abstract][Full Text] [Related]
13. The novel function of OCT4B isoform-265 in genotoxic stress.
Gao Y; Wei J; Han J; Wang X; Su G; Zhao Y; Chen B; Xiao Z; Cao J; Dai J
Stem Cells; 2012 Apr; 30(4):665-72. PubMed ID: 22247013
[TBL] [Abstract][Full Text] [Related]
14. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract][Full Text] [Related]
15. OCT4B modulates OCT4A expression as ceRNA in tumor cells.
Li D; Yang ZK; Bu JY; Xu CY; Sun H; Tang JB; Lin P; Cheng W; Huang N; Cui RJ; Yu XG; Zheng XL
Oncol Rep; 2015 May; 33(5):2622-30. PubMed ID: 25812694
[TBL] [Abstract][Full Text] [Related]
16. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
[TBL] [Abstract][Full Text] [Related]
17. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
18. Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells.
Xie Z; Tan G; Ding M; Dong D; Chen T; Meng X; Huang X; Tan Y
Nucleic Acids Res; 2010 Dec; 38(22):8027-38. PubMed ID: 20702419
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
20. A novel variant of Oct3/4 gene in mouse embryonic stem cells.
Guo CL; Liu L; Jia YD; Zhao XY; Zhou Q; Wang L
Stem Cell Res; 2012 Sep; 9(2):69-76. PubMed ID: 22683460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]